Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancrelipase with ONS for Malnutrition Risk
NCT06826105Recruiting
- Start
- Sep 2025
- Primary completion
- Jan 2027
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Randomised trial in Malnutrition comparing Pancrelipase with Placebo (2 arms). Primary endpoint: Incremental area under the curve of total branched-chained amino acid concentration at 180 months. Started Sep 2025; status: recruiting.
02
Drugs
pancrelipase
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT06826105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06826105.